From Discovery to Development: Enhancing Predictive Confidence of 3D Models to Accelerate Adoption
The 5th Edition of the PREDiCT: 3D Oncology & Tissue Models Summit will return to Boston in September with an exciting 2 tracks program featuring a breadth of latest research and real world case studies to help you accelerate your discovery and preclinical development studies for oncology and precision medicine.
This dedicated 3-day meeting will gather 30+ senior preclinical scientists, FDA, NIH and leading academics to share their journeys in advancing the use of organoids ad tissue-on-chip technology – and showcase how these models enhance their therapeutic success of preclinical pipeline.
Find out more about this must-attend meeting by registering your interest now. If you’ve an interesting story to share, we’d love to hear from you too!
“The depth of the discussion, and opportunities to hear perspectives from those leading the industry on developing 3D tissue models made this an exceptionally valuable meeting” Commercial Innovation Life Sciences Lead, Center for the Advancement of Science in Space
“I thought the conference was very focused. It was time well spent. I learned a lot and had productive networking sessions.” Biochemical & Cellular Pharmacology, Genentech
